Stewart "Dirk" Fischer

Stewart Roussin Fischer (September 1, 1924 – February 25, 2013) known professionally as Dirk Fischer or Dirty Dirk Fischer was an American composer, arranger, educator, trumpeter, and valve trombonist. Before moving to California in 1959, he spent his young adulthood in the Northern Plains, performing with and writing for territory bands booked out of Omaha, Nebraska. He was the brother of Clare Fischer.

Fischer was a faculty member at College of the Canyons, as Jazz Band Director and Instructor of Jazz Studies, from 1977 to 2005. Provided by Wikipedia
Showing 1 - 13 results of 13 for search 'Dirk Fischer', query time: 0.05s Refine Results
  1. 1
    Stable-Isotope Dilution GC–MS Measurement of Metformin in Human Serum and Urine after Derivatization with Pentafluoropropionic Anhydride and Its Application in Becker Muscular Dystrophy Patients Administered with Metformin, <span style="font-variant: small-caps">l</span>-Citrulline, or Their Combination

    Stable-Isotope Dilution GC–MS Measurement of Metformin in Human Serum and Urine after Derivatization with Pentafluoropropionic Anhydride and Its Application in Becker Muscular Dyst... by Svetlana Baskal, Alexander Bollenbach, Bettina Henzi, Patricia Hafner, Dirk Fischer, Dimitrios Tsikas

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?

    Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility? by Stephanie Kourakis, Cara A. Timpani, Judy B. de Haan, Nuri Gueven, Dirk Fischer, Emma Rybalka

    Published 2020-10-01
    Get full text
    Article
  3. 3
    Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy

    Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy by Stephanie Kourakis, Cara A. Timpani, Judy B. de Haan, Nuri Gueven, Dirk Fischer, Emma Rybalka

    Published 2021-01-01
    Get full text
    Article
  4. 4
    Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial

    Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial by Sara Nagy, Patricia Hafner, Simone Schmidt, Daniela Rubino-Nacht, Sabine Schädelin, Oliver Bieri, Dirk Fischer

    Published 2019-11-01
    Get full text
    Article
  5. 5
    Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers

    Defining metabolic migraine with a distinct subgroup of patients with suboptimal inflammatory and metabolic markers by Elena C. Gross, Niveditha Putananickal, Anna-Lena Orsini, Jean Schoenen, Dirk Fischer, Adrian Soto-Mota

    Published 2023-03-01
    Get full text
    Article
  6. 6
    Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?

    Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? by Stephanie Kourakis, Cara A. Timpani, Dean G. Campelj, Patricia Hafner, Nuri Gueven, Dirk Fischer, Emma Rybalka

    Published 2021-03-01
    Get full text
    Article
  7. 7
    Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients.

    Feasibility of Using Microsoft Kinect to Assess Upper Limb Movement in Type III Spinal Muscular Atrophy Patients. by Xing Chen, Juliane Siebourg-Polster, Detlef Wolf, Christian Czech, Ulrike Bonati, Dirk Fischer, Omar Khwaja, Martin Strahm

    Published 2017-01-01
    Get full text
    Article
  8. 8
    Mitochondrial function and oxidative stress markers in higher-frequency episodic migraine

    Mitochondrial function and oxidative stress markers in higher-frequency episodic migraine by Elena C. Gross, Niveditha Putananickal, Anna-Lena Orsini, Deborah R. Vogt, Peter S. Sandor, Jean Schoenen, Dirk Fischer

    Published 2021-02-01
    Get full text
    Article
  9. 9
    Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial

    Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial by Niveditha Putananickal, Elena C. Gross, Anna-Lena Orsini, Simone Schmidt, Patricia Hafner, Vanya Gocheva, Sara Nagy, Bettina C. Henzi, Daniela Rubino, Sabine Schädelin, Peter Sandor, Dirk Fischer

    Published 2023-05-01
    Get full text
    Article
  10. 10
    Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.

    Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study. by Patricia Hafner, Ulrike Bonati, Beat Erne, Maurice Schmid, Daniela Rubino, Urs Pohlman, Thomas Peters, Erich Rutz, Stephan Frank, Cornelia Neuhaus, Stefanie Deuster, Monika Gloor, Oliver Bieri, Arne Fischmann, Michael Sinnreich, Nuri Gueven, Dirk Fischer

    Published 2016-01-01
    Get full text
    Article
  11. 11
    Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study

    Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study by Claudia A. Chiriboga, Claudio Bruno, Tina Duong, Dirk Fischer, Eugenio Mercuri, Janbernd Kirschner, Anna Kostera-Pruszczyk, Birgit Jaber, Ksenija Gorni, Heidemarie Kletzl, Imogen Carruthers, Carmen Martin, Francis Warren, Renata S. Scalco, Kathryn R. Wagner, Francesco Muntoni, the JEWELFISH Study Group

    Published 2023-07-01
    Get full text
    Article
  12. 12
    Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study

    Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study by Claudia A. Chiriboga, Claudio Bruno, Tina Duong, Dirk Fischer, Eugenio Mercuri, Janbernd Kirschner, Anna Kostera-Pruszczyk, Birgit Jaber, Ksenija Gorni, Heidemarie Kletzl, Imogen Carruthers, Carmen Martin, Francis Warren, Renata S. Scalco, Kathryn R. Wagner, Francesco Muntoni, the JEWELFISH Study Group

    Published 2023-02-01
    Get full text
    Article
  13. 13
    Dimethyl fumarate modulates the dystrophic disease program following short-term treatment

    Dimethyl fumarate modulates the dystrophic disease program following short-term treatment by Cara A. Timpani, Stephanie Kourakis, Danielle A. Debruin, Dean G. Campelj, Nancy Pompeani, Narges Dargahi, Angelo P. Bautista, Ryan M. Bagaric, Elya J. Ritenis, Lauren Sahakian, Didier Debrincat, Nicole Stupka, Patricia Hafner, Peter G. Arthur, Jessica R. Terrill, Vasso Apostolopoulos, Judy B. de Haan, Nuri Guven, Dirk Fischer, Emma Rybalka

    Published 2023-11-01
    Get full text
    Article

Search Tools: